11β-hydroxysteroid dehydrogenase type 2 in mouse aorta -: Localization and influence on response to glucocorticoids

被引:79
作者
Christy, C [1 ]
Hadoke, PWF [1 ]
Paterson, JM [1 ]
Mullins, JJ [1 ]
Seckl, JR [1 ]
Walker, BR [1 ]
机构
[1] Univ Edinburgh, Western Gen Hosp, Sch Mol & Clin Med, Endocrinol Unit, Edinburgh EH4 2XU, Midlothian, Scotland
关键词
endothelium; glucocorticoids; mice; muscle; smooth; vascular; vasoconstriction; vasorelaxation;
D O I
10.1161/01.HYP.0000088855.06598.5B
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Both isozymes of 11 beta-hydroxysteroid dehydrogenase, which interconvert active and inactive glucocorticoids, are expressed in the mouse aortic wall. Mice deficient in 11HSD type 2 ( which converts active corticosterone into inert 11-dehydrocorticosterone) have hypertension and impaired endothelial nitric oxide activity. It has been suggested that 11HSD2 influences vascular function directly by limiting glucocorticoid-mediated inhibition of endothelium-derived nitric oxide. This study sought to determine (1) the cellular distribution of the 11HSD isozymes within the mouse aortic wall and (2) the influence of 11HSD2 on direct glucocorticoid-mediated changes in aortic function. Mouse aortas were separated into their component layers and RNA extracted for RT-PCR. Both types of corticosteroid (mineralocorticoid and glucocorticoid) receptors and both 11HSD isozymes were expressed in the aortic wall. 11HSD1 expression colocalized with alpha-smooth muscle actin (a marker for smooth muscle cells), whereas 11HSD2 colocalized with TIE-2 (a marker for endothelial cells). Functional relaxation responses of mouse aortic rings were unaltered after exposure to glucocorticoids for 24 hours. In the presence of L-arginine, glucocorticoids produced an endothelium-independent reduction of contraction; similar results were obtained with aortas from mice with genetic inactivation of 11HSD2. Incubation in medium containing L-arginine reversed the endothelial cell dysfunction associated with 11HSD2 inactivation. Thus, 11HSD2 is appropriately sited to modulate endothelial cell function, but endothelial dysfunction in 11HSD2 knockout mice cannot be explained simply by increased access of corticosterone to endothelial cell corticosteroid receptors. Therefore, additional mechanisms, possibly involving indirect effects of enhanced corticosterone action in the kidney and the resultant hypertension, must be involved.
引用
收藏
页码:580 / 587
页数:8
相关论文
共 32 条
  • [1] AGARWAL AK, 1994, J BIOL CHEM, V269, P25959
  • [2] ALBISTON AL, 1994, MOL CELL ENDOCRINOL, V105, P11
  • [3] Dexamethasone and 11-dehydrodexamethasone as tools to investigate the isozymes of 11 beta-hydroxysteroid dehydrogenase in vitro and in vivo
    Best, R
    Nelson, SM
    Walker, BR
    [J]. JOURNAL OF ENDOCRINOLOGY, 1997, 153 (01) : 41 - 48
  • [4] Brem Andrew S., 1997, Life Sciences, V60, P207
  • [5] Glucocorticoids inhibit the expression of calcium-dependent potassium channels in vascular smooth muscle
    Brem, AS
    Bina, RB
    Mehta, S
    Marshall, J
    [J]. MOLECULAR GENETICS AND METABOLISM, 1999, 67 (01) : 53 - 57
  • [6] Localization of 2 11β-OH steroid dehydrogenase isoforms in aortic endothelial cells
    Brem, AS
    Bina, RB
    King, TC
    Morris, DJ
    [J]. HYPERTENSION, 1998, 31 (01) : 459 - 462
  • [7] Light and electron microscopy localization of the 11ß-hydroxysteroid dehydrogenase type I enzyme in the rat
    Brereton, PS
    van Driel, RR
    Suhaimi, FBH
    Koyama, K
    Dilley, R
    Krozowski, Z
    [J]. ENDOCRINOLOGY, 2001, 142 (04) : 1644 - 1651
  • [8] Cloning and production of antisera to human placental 11 beta-hydroxysteroid dehydrogenase type 2
    Brown, RW
    Chapman, KE
    Kotelevtsev, Y
    Yau, JLW
    Lindsay, RS
    Brett, L
    Leckie, C
    Murad, P
    Lyons, V
    Mullins, JJ
    Edwards, CRW
    Seckl, JR
    [J]. BIOCHEMICAL JOURNAL, 1996, 313 : 1007 - 1017
  • [9] Induction of 11β-hydroxysteroid dehydrogenase type 1 but not-2 in human aortic smooth muscle cells by inflammatory stimuli
    Cai, TQ
    Wong, BM
    Mundt, SS
    Thieringer, R
    Wright, SD
    Hermanowski-Vosatka, A
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2001, 77 (2-3) : 117 - 122
  • [10] VASCULAR TYPE-I ALDOSTERONE BINDING-SITES ARE PHYSIOLOGICAL MINERALOCORTICOID RECEPTORS
    FUNDER, JW
    PEARCE, PT
    SMITH, R
    CAMPBELL, J
    [J]. ENDOCRINOLOGY, 1989, 125 (04) : 2224 - 2226